Clinic
Tallahassee Neurology Specialists, P.L.
Tallahassee Neurology Specialists, P.L. was paid $751K by Medicaid between Sep 2019 and Nov 2024, across 16 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 78% of everything it billed.
33Billing provider infoTALLAHASSEE NEUROLOGY SPECIALISTS, P.L.
TALLAHASSEE, FL 32308
TALLAHASSEE, FL 32308
33aNPI1326357005assigned 09/29/2010
33bProvider typeMulti-Specialty Clinic/Center
28Total paid$751K
24GClaims19,992
24DCodes billed16
24AFirst – last monthSep 2019 – Nov 2024
Compared with peers
Next to other Multi-Specialty Clinic/Center providers in Florida
Rank by total paid#30 of 91
Median peer was paid$230K
This provider vs. median3.3×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 237 | $198.47 | |
| 2020 | 2,665 | $41K | |
| 2021 | 2,660 | $82K | |
| 2022 | 3,280 | $172K | |
| 2023 | 5,953 | $257K | |
| 2024incomplete | 5,197 | $199K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 78% | 14,644 | 11,323 | $585K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 11% | 1,245 | 965 | $84K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 8.0% | 2,646 | 2,197 | $60K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | <1% | 116 | 99 | $6K |
| 95819 | <1% | 32 | 27 | $4K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | <1% | 68 | 57 | $3K |
| G0483 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 22 or more drug class(es), including metabolite(s) if performed | <1% | 17 | 14 | $3K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 519 | 348 | $2K |
| 99233 | Hospital visit by a doctor, follow-up day (complex)Prolong inpt eval add15 m | <1% | 32 | 12 | $2K |
| 99223 | Prolong inpt eval add15 m | <1% | 16 | 14 | $1K |
| 99203 | Doctor's office visit, new patient (routine)Office or other outpatient visit for the evaluation and management of a new patient, low complexity | <1% | 14 | 12 | $769.57 |
| 99406 | <1% | 63 | 54 | $334.68 |
4 more codes
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialJONES, ROLAND (OWNER)